I mean, we admittedly are kind of weak in the west and so we’re analyzing targets over there. And then in the Northeast, we could use an acquisition target as well, but those guys are already in our pipeline and we’re working through them and we have some leads. So, we’re excited maybe to grow in those geographic apps in a different way.
Charlie Montang: Great. Well, thanks for answering my questions and I’ll hop back in the queue.
Operator: Our next question comes from the line of Doug Cooper with Beacon Securities. Please proceed with your question.
Doug Cooper: Good morning guys and congratulations on a great quarter. Todd, first of all sequentially the EBITDA margin of 500 basis points, is that strictly I guess because of the increased revenue sequentially and G&A was flat and the flow through, is that strong?
Todd Zehnder: That’s the primary reason. Yes, Doug. I mean, we obviously did a lot of good work on G&A. Some of that will continue to translate into or most of that will continue translate into good cost management in 2023. The fourth quarter from a realization and a bad debt standpoint is always going to be better. It’s the least amount of impact for patients changing insurances and all the things that cause challenges really in the first quarter that we end up fighting headwinds on, which is why our revenue guidance may look muted to some people on a sequential basis, but if you look year-over-year, we’re up 27%. So, the growth rates are still intact. I want to be clear about that. But all that combined gives you a really good margin profile for the fourth quarter.
Doug Cooper: Great. And the CPI or the Medicare CPI adjustments, I guess, was started January 1, we’re sitting here March 3, can you give us any indication of how that €“ you see that impacting here?
Todd Zehnder: Yes. I think right now the way that we’re starting to see it shake out and it’s early because we only have really one-month closed out. but we’re probably seeing somewhere between on a net-net basis, somewhere around 4% to 5% across all of our revenue. You got to remember it only hits the Medicare and any contracts that are tied to Medicare. And then the rate increase is anywhere like for vents and 8.7% pretty much, because none of those competitive bids and it’s countrywide. For oxygen and path, it’s a little bit more skewed throughout depending on what area it comes from. And then it obviously doesn’t apply to the revenue that isn’t contracted to that or say our staffing revenue. So, I think right now we’re comfortable saying somewhere between 4% to 5% of gross revenue is seeing the uptick in the first quarter.
Doug Cooper: And you think that’s, aside from say Q1 with the bad debt provisions, maybe a little higher or so forth, but you see that flowing through to the bottom line for margin expansion, all of the things being equal?
Todd Zehnder: Yes. I mean, obviously, we have to continue to do our cost management like we’ve been doing and that will €“ as we continue to hire, there will be some G&A that comes along with it, but we would expect see the revenue growth come with that as well. So, long answer to yes, I do see that flowing its way through the bottom line.
Doug Cooper: Okay. And Casey, just in terms of the operations, can you give us an idea? Did you have some geographic expansion this quarter? Maybe just talk about new territories and just a general update on how the is progressing?
